What should the blood pressure be in patients with chronic kidney disease?
作者信息
Aronow Wilbert S
机构信息
Division of Cardiology, Department of Medicine, Westchester Medical Center/New York Medical College, Valhalla, NY, USA.
出版信息
Ann Transl Med. 2017 Feb;5(3):48. doi: 10.21037/atm.2017.01.15.
Abstract
摘要
相似文献
1
What should the blood pressure be in patients with chronic kidney disease?慢性肾病患者的血压应该是多少？
Ann Transl Med. 2017 Feb;5(3):48. doi: 10.21037/atm.2017.01.15.
2
The relationships between visit-to-visit blood pressure variability and renal and endothelial function in chronic kidney disease.慢性肾脏病中就诊间血压变异性与肾脏及内皮功能的关系。
Hypertens Res. 2015 Mar;38(3):193-8. doi: 10.1038/hr.2014.163. Epub 2014 Dec 4.
3
QardioArm Upper Arm Blood Pressure Monitor Against Omron M3 Upper Arm Blood Pressure Monitor in Patients With Chronic Kidney Disease: A Validation Study According to the European Society of Hypertension International Protocol Revision 2010.慢性肾脏病患者使用QardioArm上臂式血压监测仪与欧姆龙M3上臂式血压监测仪的对比：一项依据2010年欧洲高血压学会国际协议修订版进行的验证研究
J Med Internet Res. 2019 Dec 2;21(12):e14686. doi: 10.2196/14686.
4
[Analysis of the difference of serum immunoglobulins, β2-microglobulin and transferrin in pre-eclampsia and pregnancies complicated with chronic kidney disease].[子痫前期与合并慢性肾脏病妊娠患者血清免疫球蛋白、β2-微球蛋白及转铁蛋白差异分析]
Zhonghua Fu Chan Ke Za Zhi. 2018 Feb 25;53(2):77-81. doi: 10.3760/cma.j.issn.0529-567X.2018.02.002.
5
Association between blood pressure and target organ damage in patients with chronic kidney disease and hypertension: results of the APrODiTe study.慢性肾脏病合并高血压患者的血压与靶器官损害的相关性：APrODiTe 研究结果。
Hypertens Res. 2014 Feb;37(2):172-8. doi: 10.1038/hr.2013.127. Epub 2013 Sep 19.
6
Time for reflection predicts the progression of renal dysfunction in patients with nondiabetic chronic kidney disease.
Clin Exp Hypertens. 2009 May;31(3):220-30. doi: 10.1080/10641960902822476.
7
Hypertension awareness, treatment, and control in chronic kidney disease.慢性肾脏病中的高血压知晓率、治疗及控制情况
Am J Med. 2008 Apr;121(4):332-40. doi: 10.1016/j.amjmed.2007.11.025.
8
Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis.慢性肾脏病的进展：血压控制、蛋白尿及血管紧张素转换酶抑制的作用：一项患者水平的荟萃分析
Ann Intern Med. 2003 Aug 19;139(4):244-52. doi: 10.7326/0003-4819-139-4-200308190-00006.
9
Longitudinal Blood Pressure in Late-Stage Chronic Kidney Disease and the Risk of End-Stage Kidney Disease or Mortality (Best Blood Pressure in Chronic Kidney Disease Study).晚期慢性肾脏病患者的纵向血压与终末期肾病风险或死亡率（慢性肾脏病最佳血压研究）
Hypertension. 2017 Dec;70(6):1210-1218. doi: 10.1161/HYPERTENSIONAHA.117.09855. Epub 2017 Oct 23.
10
Blood pressure control in chronic kidney disease: A cross-sectional analysis from the German Chronic Kidney Disease (GCKD) study.慢性肾脏病中的血压控制：来自德国慢性肾脏病（GCKD）研究的横断面分析。
PLoS One. 2018 Aug 20;13(8):e0202604. doi: 10.1371/journal.pone.0202604. eCollection 2018.
本文引用的文献
1
Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial.强化与标准血压控制对≥75岁成年人心血管疾病结局的影响：一项随机临床试验。
JAMA. 2016 Jun 28;315(24):2673-82. doi: 10.1001/jama.2016.7050.
2
Recommendations for Intensive Blood Pressure Lowering in High-Risk Patients, the Canadian Viewpoint.高危患者强化降压的建议：加拿大视角
Hypertension. 2016 Jul;68(1):3-5. doi: 10.1161/HYPERTENSIONAHA.116.07573. Epub 2016 May 9.
3
Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension.加拿大高血压协会《2016年加拿大高血压教育计划血压测量、诊断、风险评估、预防及治疗指南》
Can J Cardiol. 2016 May;32(5):569-88. doi: 10.1016/j.cjca.2016.02.066. Epub 2016 Mar 10.
4
Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis.强化降压对心血管和肾脏结局的影响：更新的系统评价和荟萃分析。
Lancet. 2016 Jan 30;387(10017):435-43. doi: 10.1016/S0140-6736(15)00805-3. Epub 2015 Nov 7.
5
A Randomized Trial of Intensive versus Standard Blood-Pressure Control.强化与标准血压控制的随机试验
N Engl J Med. 2015 Nov 26;373(22):2103-16. doi: 10.1056/NEJMoa1511939. Epub 2015 Nov 9.
6
Chapter 4: Blood pressure management in CKD ND patients with diabetes mellitus.第4章：糖尿病合并慢性肾脏病非透析患者的血压管理。
Kidney Int Suppl (2011). 2012 Dec;2(5):363-369. doi: 10.1038/kisup.2012.54.
7
Chapter 3: Blood pressure management in CKD ND patients without diabetes mellitus.第3章：非糖尿病慢性肾脏病患者的血压管理
Kidney Int Suppl (2011). 2012 Dec;2(5):357-362. doi: 10.1038/kisup.2012.53.
8
Combined angiotensin inhibition for the treatment of diabetic nephropathy.联合应用血管紧张素抑制剂治疗糖尿病肾病。
N Engl J Med. 2013 Nov 14;369(20):1892-903. doi: 10.1056/NEJMoa1303154. Epub 2013 Nov 9.
9
Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials.降压治疗对伴有和不伴有慢性肾脏病的人群主要心血管事件的影响：随机对照试验的荟萃分析。
BMJ. 2013 Oct 3;347:f5680. doi: 10.1136/bmj.f5680.
10
Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis.强化降压对慢性肾脏病进展的影响：系统评价和荟萃分析。
CMAJ. 2013 Aug 6;185(11):949-57. doi: 10.1503/cmaj.121468. Epub 2013 Jun 24.
Zotero 插件